Systematic reviews and lifelong diseases
- PMID: 12183313
- PMCID: PMC1123891
- DOI: 10.1136/bmj.325.7360.381
Systematic reviews and lifelong diseases
Figures
References
- 
    - Li wan Po A, Herxheimer A, Poolsup N, Aziz Z. 8th Cochrane Colloquium abstract. Cape Town, South Africa. 2001. How do Cochrane reviewers address adverse effects of drug therapy?
 
- 
    - Elphick HE, Tan A. Cochrane Library. Issue 3. Oxford: Update Software; 2001. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. - PubMed
 
- 
    - Schulz K, Chalmers I, Hayes R, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effect in controlled clinical trials. JAMA. 1995;273:408–412. - PubMed
 
- 
    - Smith A, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, et al. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr. 1999;134:413–421. - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
         
              